Thus, GDNF can only function efficiently when enough dopaminergic neurons are still around which express the Ret receptor.5, 29 Late stage PD patients with too few dopaminergic cells and strongly reduced striatal dopaminergic innervation will most likely not be able to respond efficiently to GDNF and should be excluded from the clinical GDNF trials. Here, GDNF is linked to Parkinson disease.